MedPath

To check the effect of intravenous dexmedetomidine versus dexmedetomidine in subarachnoid space on pain in patients undergoing surgery under spinal anaesthesia with heavy bupivacaine

Not yet recruiting
Conditions
Injury of unspecified muscle and tendon at lower leg level, (2) ICD-10 Condition: O||Medical and Surgical, (3) ICD-10 Condition: S828||Other fractures of lower leg,
Registration Number
CTRI/2022/07/044353
Lead Sponsor
Department of anesthesiology Sawai Man Singh medical College and attached hospital
Brief Summary

To see the effect of intrathecal dexmedetomidine versus intravenous dexmedetomidine on duration and density of block in surgeries under subarachnoid block

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
90
Inclusion Criteria

ASA grade 1 and 2 Patients scheduled for elective surgeries under subarachnoid block.

Exclusion Criteria

Patient not willing to participate ASA grade 3 and 4 Cases with sepsis or infection on local site History of hypovolemia,anemia, compromised cardiac function Cases with raised intracranial tension History of alcohol abuse or opioid intake or sedative medication History of blood coagulopathies Patient allergic to drug used for study Uncooperative patient Failure of spinal anesthesia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean time duration of first dose of rescue analgesia24 hours
Mean time duration of two segment regression24 hours
Secondary Outcome Measures
NameTimeMethod
Total dose of rescue analgesia given in 24 hours Post operative periodMean time to reach highest sensory and motor blockade

Trial Locations

Locations (1)

SMS medical College and attached hospital, Jaipur

🇮🇳

Jaipur, RAJASTHAN, India

SMS medical College and attached hospital, Jaipur
🇮🇳Jaipur, RAJASTHAN, India
Dr Manu
Principal investigator
9478315095
manudadhwal93@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.